Orchard Therapeutics plc Overview

Orchard Therapeutics plc Other Income Expense Net

Other Income/Expense Net for ORTX.

Quarterly Other Income/Expense

-$12.74M

↑ 44.8% YoY

As of Sep 30, 2023

Annual Other Income/Expense (TTM)

$7.89M

↑ 116.58% YoY

Trailing 12 months ending Sep 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin